My research has centered on understanding the underlying cellular mechanisms and identifying novel treatments for neurodegenerative, neuromuscular, and inflammatory diseases. My current focus has been on developing gene therapies for diseases that affect the eye like uveitis, retinitis pigmentosa, and age-related macular degeneration.
Earlier in my career I studied muscular dystrophies associated with mutations in dysferlin and members of the dystrophin-glycoprotein complex. While these are very different diseases from those that affect the eye, the underlying cell biology share common features. For example, inherited mutations can have a negative consequence on calcium signaling, cell membrane biology, or cytoskeletal dynamics, which ultimately cause different diseases depending on the cell type affected (i.e. muscle myofibers or retinal neurons).
Previous work is highlighted below and a complete list of publications and abstracts can be found on Google Scholar.
Keystone Symposia on Molecular & Cellular Biology: Targeting Dry Age-related Macular Degeneration 2024
Poster Presentation & Short Talk: "Suprachoroidal Delivery of a Novel Capsid Expressing a C5 Inhibitor as a Potential Treatment for Dry Age-Related Macular Degeneration"
For a complete list of publications and abstracts, please see Google Scholar.